Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Nowadays conception of blood pressure (BP) variability (BPV) includes a number of indicators related to various physiological factors. All the indexes are calculated with the standard deviation (SD) or more complex formulas, including SD. BPV main varieties are considered a 24-hour BPV (measured by ambulatory BP monitoring – ABPM), midterm BPV (BP self-control or home BP – HBP), and long-term, visit-to-visit, BPV (traditional BP measurement or office BP – OBP). The 24-hour BPV was the main subject of study for many years. Recently significant attention has been paid to the visit-to-visit BPV assessment. Retrospective meta-analysis showed that in a cohort of patients after stroke or transient ischemic attack, this index was a strong and independent (from the average BP level) predictor of stroke. In ASCOT-BPLA study visit-to-visit systolic BPV also was a strong predictor of stroke and coronary events. Long-term BPV in patients of amlodipine/perindopril treatment group was significantly lower than this in patients of atenolol/diuretic group during the follow-up that was associated with a lower risk of cardiovascular complications. However , the concept of visit-to-visit BPV use for risk stratification and monitoring of antihypertensive therapy efficacy is associated with significant limitations (basic data is obtained in the post hoc analysis, difficulties in objective evaluation of prognostic significance of indicators, their dependence on medication adherence, etc.). The HBP self-control is a promising approach to the BPV analysis; it may be the "happy medium" between ABPM and OPB. New-designed prospective comparative studies are needed to evaluate the clinical significance of the various BPV parameters.

About the Author

V. M. Gorbunov
State Research Center for Preventive Medicine
Russian Federation


1. Parati G., Di Rienzo M., Mancia G., Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G, eds. Handbook of Hypertension. Amsterdam, the Netherlands: Elsevier; 1997:117–169.

2. Poulter N.R. Can we improve BP control rates? Lessons from the Health Survey for England 2006. Medico-gaphia 2010; 32 (3): 227–234.

3. Wolf-Maier K., Cooper R.S., Banegas J.R. et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and United States. JAMA 2003;289:2363–9.

4. Mancia G., Bombelli M., Facchetti R. et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265–70.

5. Stolarz-Skrzypek K., Thijs L., Richart T. et al. Blood Pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome. Hypertension Research 2010;33:757–766.

6. Gorbunov V.M., Oganov R.G., Deev A.D. Comparative information value of different ways of analyzing the results of ambulatory blood pressure monitoring to assess the effectiveness of antihypertensive therapy. Kardiovaskulyarnaya Terapiya i Profilaktika 2003;(1):17–25. Russian (Горбунов В.М., Оганов Р.Г., Деев А.Д. Сравнительная информативность различных способов анализа результатов суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваскулярная Терапия и Профилактика 2003;(1):17–25).

7. Rothwell P.M., Howard S.C., Dolan E. et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure and episodic hypertension. Lancet 2010;375:895–905.

8. Rothwell P.M., Howard S.C., Dolan E. et al. Effects of ß-blockers and calcium channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010;9:469–80.

9. Webb A.J.S., Fisher U., Mehta Z., Rothwell P.M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010;374:906–15.

10. Parati G., Bilo G. Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability? Evidence from day-to-day home blood pressure monitoring. Hypertension 2012:59:1091–1093.

11. Mancia G., Facchetti R., Parati G., Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effect of antihypertensive treatment. J Hypertens 2012;30:1241–51.

12. Arabidze G.G., editor. Daily monitoring of blood pressure in hypertension (methodological issues). Moscow: RKNPK; 1996. Russian (Арабидзе Г.Г., редактор. Суточное мониторирование артериального давления при гипертонии (методические вопросы). М.: РКНПК; 1996).

13. Gorbunov V.M. Modern aspects of the practical use of ambulatory blood pressure monitoring. Moscow, 2012 (in print). Russian (Горбунов В.М. Современные аспекты практического использования суточного мониторирования артериального давления. М., 2012 (в печати)).

14. Stergiou G.S., Parati G. How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability. Hypertension 2011;57:00–00.

15. Bilo G., Giglio A., Styczkiewicz K. et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007;25:2058–2066.

16. Mena L., Pintos S., Queipo N.V. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2003; 23: 505–511.

17. Kikuya M., Ohkubo T., Metoki H. et al. Day-to-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension 2008:52:1045–1050.

18. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-home study. Hypertension 2012;59:212–218.

19. Dolan E., O’Brien E. Blood pressure variability: Clarity for clinical practice. Hypertension 2010;56:179–81.

20. Cuspidi C., Ochoa J.P., Parati G. Seasonal variatios in blood pressure: a complex phenomenon. J Hypertens 2012;30:1315–1320.

21. Li Y, Thijs L, Hansen TW. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010;55(4):1040–8.

22. Rothwell P.M., Coull A.J., Giles M.F. et al. for the Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925–33.

23. Farrell B., Godwin J., Richards S., Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–1054.

24. The ESPS Group. The European Stroke Prevention Study (ESPS). Principal end-points. Lancet 1987;330:1351–54.

25. The Dutch TIA Study Group, A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patient after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med 1991;325:1261–66.

26. Poulter N.R., Wedel H., Dahlöf B. et al. For the ASCOT investigators. Role of blood pressure and other variables in the differential cardiovascular events rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005;366:907–13.

27. Muntner P., Schimbo D., Tonelli M. et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57: 160–6.

28. Zhang Y., Agnoletti D., Safar M.E. et al. Effect of Antihypertensive agents on blood pressure variability. The Natrilix SR versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study. Hypertension 2011;58:155–60.

29. Matsui Y., O’Rourke M.F., Hoshide S. et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure. Hypertension 2012;59:1132–8.

30. NICE guidelines August 2011; CG127 Hypertension: Clinical management of primary hypertension in adults. Available on: Date of access: 04/12/2012.

31. Mancia G., Parati G., Pomidossi G. et al. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986;8:155–61.

32. Parati G., Faini G., Valentini M. Blood pressure variability: its measurement and significance in hypertension. Curr Hypertens Res 2006;8:199–204.

33. Modesti P.A., Morabito M., Bertolozzi I. et al. Weather-related changes in 24-hour blood pressure profile. Effects of age and implications for hypertension management. Hypertension 2006;47:155– 161.

34. Frattola A., Parati G., Castiglioni P. et al. Lacidipine and blood pressure variability in diabetic hypertensive patients. Hypertension 2000;36:622–628.

35. Mancia G. Short- and Long-term blood pressure variability. Present and future. Hypertension 2012;60:00–00.

For citation:

Gorbunov V.M. MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE. Rational Pharmacotherapy in Cardiology. 2012;8(6):810-818. (In Russ.)

Views: 503

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)